DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Kang Z, Chen JJ, Yu Y et al.
Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response.
Clin Cancer Res 2011;
17: 3181-3192
We do not assume any responsibility for the contents of the web pages of other providers.